Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia
general13
Centers
2
Active Trials
$4.8B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Refractory Anemia | 13 |
Top Centers for Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | — |
| 2 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | — |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | — |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | — |
| 5 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | — |
| 6 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | — |
| 7 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | — |
| 8 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | — |
| 9 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | — |
| 10 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | — |
| 11 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | — |
| 12 | Cleveland Clinic Cancer CenterCleveland, OH | — |
| 13 | University of Illinois Cancer CenterChicago, IL | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →